| (1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-1,9-dihydroxy-15-{[(2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoyl]oxy}-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl be |
| (1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-1,9-dihydroxy-15-{[(2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoyl]oxy}-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0;{3,10}.0;{4,7}]heptadec-13-en-2-yl be |
| (1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-BIS(ACETYLOXY)-1,9-DIHYDROXY-15-{[(2R,3S)-2-HYDROXY-3-PHENYL-3-(PHENYLFORMAMIDO)PROPANOYL]OXY}-10,14,17,17-TETRAMETHYL-11-OXO-6-OXATETRACYCLO[11.3.1.0(3),(1)?.0?,?]HEPTADEC-13-EN-2-YL BENZ |
| (2alpha,5beta,7beta,10beta,13alpha)-4,10-bis(acetyloxy)-1,7-dihydroxy-13-({(2R,3S)-2-hydroxy-3-phenyl-3-[(phenylcarbonyl)amino]propanoyl}oxy)-9-oxo-5,20-epoxytax-11-en-2-yl benzoate |
| (2aR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha R*,betaS*),11alpha,12alpha,12balpha))-beta-(Benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12 |
| (2aR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha R*,betaS*),11alpha,12alpha,12balpha))-beta-(Benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11 |
| (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-Dodecahydro 4,6,9,11,12,12b-hexahydroxy-4a,8,13,13-tetramethyl-7,11-methano 5Hcyclodeca(3,4)benz(1,2-b)oxet-5-one 6,12b-diacetate, |
| (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-Dodecahydro-4,6,9,11,12,12b-hexahydroxy-4a,8,13,13-tetramethyl-7,11-methano-5H-cyclodeca(3,4)benz(1,2-b)oxet-5-one 6,12b-diacetate, 12-benzoate, 9-ester wi |
| (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (aR,bS)-b-( |
| (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-9-(((2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl)oxy)-12-(benzoyloxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3 |
| (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-9-(((2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl)oxy)-12-(benzoyloxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-3,4,4a,5,6,9,10,11,12,12a-decahydro-1H-7,11-methanocyclodeca[3,4]benzo[ |
| (NAB)-Paclitaxel |
| [diacetoxy-[(2R,3S)-3-benzamido-2-hydroxy-3-phenyl-propanoyl]oxy-dihydroxy-tetramethyl-oxo-[?]yl] benzoate |
| 069P624 |
| 10337-EP2269989A1 |
| 10337-EP2270018A1 |
| 10337-EP2272827A1 |
| 10337-EP2272832A1 |
| 10337-EP2277507A1 |
| 10337-EP2277865A1 |
| 10337-EP2277876A1 |
| 10337-EP2280012A2 |
| 10337-EP2280014A2 |
| 10337-EP2281815A1 |
| 10337-EP2281820A2 |
| 10337-EP2286795A1 |
| 10337-EP2287168A2 |
| 10337-EP2289876A1 |
| 10337-EP2289892A1 |
| 10337-EP2292233A2 |
| 10337-EP2292234A1 |
| 10337-EP2292614A1 |
| 10337-EP2292615A1 |
| 10337-EP2295412A1 |
| 10337-EP2295413A1 |
| 10337-EP2295416A2 |
| 10337-EP2298748A2 |
| 10337-EP2298754A1 |
| 10337-EP2298772A1 |
| 10337-EP2298780A1 |
| 10337-EP2301533A1 |
| 10337-EP2301536A1 |
| 10337-EP2301538A1 |
| 10337-EP2301928A1 |
| 10337-EP2301933A1 |
| 10337-EP2301940A1 |
| 10337-EP2302382A2 |
| 10337-EP2302383A2 |
| 10337-EP2305243A1 |
| 10337-EP2305250A1 |
| 10337-EP2305640A2 |
| 10337-EP2305642A2 |
| 10337-EP2305671A1 |
| 10337-EP2305679A1 |
| 10337-EP2305689A1 |
| 10337-EP2305808A1 |
| 10337-EP2308833A2 |
| 10337-EP2308839A1 |
| 10337-EP2308861A1 |
| 10337-EP2311455A1 |
| 10337-EP2311808A1 |
| 10337-EP2311827A1 |
| 10337-EP2311829A1 |
| 10337-EP2314295A1 |
| 10337-EP2314574A1 |
| 10337-EP2316452A1 |
| 10337-EP2316832A1 |
| 10337-EP2316833A1 |
| 12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine |
| 1203669-79-7 |
| 157069-30-2 |
| 33069-62-4 |
| 4alpha,10beta-bis(acetyloxy)-13alpha-[(2S,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyloxy]-1,7beta-dihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate |
| 5?,20-Epoxy-1,7?-dihydroxy-9-oxotax-11-ene-2?,4,10?,13?-tetrayl 4,10-diacetate 2-benzoate 13-[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoate] |
| 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine |
| 7-epi-Paclitaxel |
| 7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv. |
| 7,11-METHANO-5H-CYCLODECA[3,4]BENZ[1,2-B]OXETE BENZENEPROPANOIC ACID DERIV. |
| 7,4]benz[1,2-b]oxete,benzenepropanoic acid deriv. |
| AB00513812 |
| AB00513812-02 |
| AB00513812-03 |
| AB0069184 |
| ABI 007 |
| ABI-007 |
| ABP000252 |
| Abraxane (albumin-bound suspension) |
| Abraxane (TN) |
| Abraxane I.V. Suspension |
| AC1L1VJI |
| ACN-032459 |
| ACon1_002231 |
| ACT02709 |
| AK108391 |
| AKOS007930675 |
| AKOS015969673 |
| AKOS025312303 |
| AM022415 |
| ANX-513 |
| Anzatax |
| BDBM50001839 |
| Benzenepropanoic acid, 6,12b-bis(acetyl oxy)-12-(benzoyloxy)- 2a,3,4,4a,5,6,9,10,11,12,12a,12b,- dodecahydro-4,11- dihydroxy-4a,8,13,13-tetramethyl-5-oxo- 7,11-methano- 1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, [2aR- [2a.a |
| Benzenepropanoic acid, b-(benzoylamino)-.alpha.-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11 |
| Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13 |
| Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,1 |
| Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H |
| Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b |
| BIDD:PXR0046 |
| Bio-0076 |
| BMS 181339-01 |
| BMS-181339 |
| BMS-181339-01 |
| BPBio1_000320 |
| BRD-K62008436-001-03-1 |
| BSPBio_000290 |
| Capxol |
| CAS-33069-62-4 |
| CCG-220155 |
| CCRIS 8143 |
| CHEBI:45863 |
| CHEMBL428647 |
| cMAP_000068 |
| Coroflex Please |
| CS-1145 |
| Cyclopax |
| Cynviloq |
| Cypher select |
| D00491 |
| DB01229 |
| DHP 107 |
| DHP-107 |
| DHP-208 |
| DRG-0190 |
| DSSTox_CID_3413 |
| DSSTox_GSID_23413 |
| DSSTox_RID_77016 |
| DTS-301 |
| DTXSID9023413 |
| Ebetaxel |
| EmPAC |
| EndoTAG 1 |
| EndoTAG-1 |
| Genaxol |
| Genetaxyl |
| Genexol |
| Genexol-PM |
| GS-6554 |
| GTPL2770 |
| HMS2090D07 |
| HMS2095O12 |
| HMS2231A16 |
| HSDB 6839 |
| HY-B0015 |
| IG 001 |
| Infinnium |
| Intaxel |
| KBio2_002509 |
| KBio2_005077 |
| KBio2_007645 |
| KBio3_002987 |
| KBioGR_002509 |
| KBioSS_002517 |
| LEP-ETU |
| LipoPac |
| Liposome-entrapped paclitaxel easy-to-use |
| M-8858 |
| MBT 0206 |
| MEGxp0_001940 |
| MFCD00869953 |
| Mitotax |
| MLS002154218 |
| MLS002695976 |
| MolPort-001-742-627 |
| MPI-5018 |
| N1361 |
| N88686 |
| NA090030 |
| nab-paclitaxel |
| nabpaclitaxel |
| Nanoparticle albumin bound paclitaxel |
| Nanotaxel |
| Nanoxel |
| NCGC00164367-01 |
| NCGC00164367-02 |
| NCGC00164367-03 |
| NCGC00164367-04 |
| NCGC00164367-05 |
| NCI60_000601 |
| NK 105 |
| Nova-12005 |
| NP-010981 |
| NSC 125973 |
| NSC-125973 |
| NSC-745099 |
| NSC125973 |
| NSC745099 |
| OAS-PAC-100 |
| OncoGel |
| Onxal |
| Onxol |
| P-SSMM-VIP |
| P88XT4IS4D |
| Paclical |
| Pacliex |
| Pacligel |
| paclitaxel |
| Paclitaxel (JAN/USP/INN) |
| Paclitaxel (Taxol) |
| Paclitaxel [USAN:USP:INN:BAN] |
| Paclitaxel natural for peak identification, European Pharmacopoeia (EP) Reference Standard |
| Paclitaxel semi-synthetic for peak identification, European Pharmacopoeia (EP) Reference Standard |
| Paclitaxel semi-synthetic for system suitability, European Pharmacopoeia (EP) Reference Standard |
| Paclitaxel-SSMM-VIP |
| Paclitaxel, Antibiotic for Culture Media Use Only |
| Paclitaxel, European Pharmacopoeia (EP) Reference Standard |
| Paclitaxel, from semisynthetic (from Taxus sp.), >=97% |
| Paclitaxel, from Taxus brevifolia, >=95% (HPLC), powder |
| Paclitaxel, From Taxus brevifolia, 95% |
| Paclitaxel, from Taxus yannanensis, powder |
| Paclitaxel, pharmaceutical secondary standard; traceable to USP, PhEur |
| Paclitaxel, United States Pharmacopeia (USP) Reference Standard |
| Paclitaxel/ |
| Padexol |
| Paxceed |
| Paxene |
| Paxoral |
| PL002062 |
| Plaxicel |
| Prestwick3_000155 |
| Q-201533 |
| QW 8184 |
| RCINICONZNJXQF-MZXODVADSA-N |
| RL03195 |
| SCHEMBL3976 |
| SDP-013 |
| Sindaxel |
| SMR000857385 |
| SR-01000075350 |
| SR-01000075350-9 |
| ST2419771 |
| SY016928 |
| Tax-11-en-9-one, 5beta,20-epoxy-1,2alpha,4,7beta,10beta,13alpha- hexahydroxy-, 4,10-diacetate 2-benzoate, 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine (8CI) |
| Tax-11-en-9-one, 5beta,20-epoxy-1,2alpha,4,7beta,10beta,13alpha-hexahydroxy-, 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine (8CI) |
| Tax-11-en-9-one,20-epoxy-1,2.alpha.,4,7.beta., 10.beta.,13.alpha.- hexahydroxy-, 4,10-diacetate 2- benzoate,13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine |
| TaxAlbin |
| TAXOL |
| TAXOL (TN) |
| Taxol (TN) (Bristol Meyers) |
| Taxol A |
| Taxus Express |
| Taxus Liberte |
| Taxus stent |
| Tocosol Paclitaxel |
| Tox21_112107 |
| UNII-P88XT4IS4D |
| Vascular Wrap |
| Xorane |
| Yewtaxan |
| ZINC96006020 |
| Zisu |
| ZX-AFC000078 |
